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INTRODUCTION 
As per WHO, Drug utilization study is one of the im-
portant tool that deals with the marketing, distribution 
and prescription pattern of drugs and helpful to assess 
the subsequent impact of these factors on the medical 
and socioeconomic status of patients [1]. Drug utiliza-
tion studies are very important in the understanding of 
the prescription pattern of drugs as well as to find out 
the quality of prescription in terms of rationality, drug 
interactions and financial burden of disease to the indi-
vidual. Periodic auditing of prescriptions in term of drug 
utilization study is an important tool to enhance the effi-
cacy of the treatment, to decrease the risk of the adverse 
effects, to give cost-effective treatment and to provide 
useful feedback to the clinician [2, 3]. 
Prevalence of dermatological diseases is very high 
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throughout the world, and in day to day practice, a quar-
ter of the cases are related to dermatological manifesta-
tions [4, 5]. Skin disorders have been reported as 18th 
leading cause of health burden worldwide and 4th lead-
ing cause of nonfatal health burden in 2010 globally [6]. 
Worldwide, 2% of the Outpatient Department (OPD) 
consultations are related to skin disorders [7]. Skin dis-
orders such as pyoderma, acne, urticaria, dermatitis, 
scabies, fungal skin infections and alopecia are common 
in India [8]. In studies conducted in the Out Patient De-
partment (OPD) of dermatology in North Palestine and 
Western Nepal, irrationalities in the prescriptions have 
been reported [2, 9]. Similar problems were also detect-
ed in studies conducted among dermatologic outpatients 
in India. [10, 11].  
In collaboration with dermatology OPD, we had 
planned the present study to find out the pattern of skin 
diseases in this region and the common drugs prescribed 
for them.  
MATERIAL AND METHODOLOGY    
Study Design: It was a descriptive, cross-sectional, 
retrospective observational study. 
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Study period: The study was conducted during the peri-
od of 1st September 2018 to 30th November 2018. 
Study Place: Study was conducted in the dermatology 
department of tertiary care hospital of Western Maha-
rashtra  
Ethical Approval: The study was conducted after ob-
taining the permission of the Institutional Ethics Com-
mittee and permission also taken from the department of 
dermatology.  
Inclusion Criteria: OPD records of the patients who 
visited dermatology OPD between the period 1st March 
2018 to 31st August 2018 were analysed during the 
study period (1st September 2018 to 30th November 
2018). 
Exclusion Criteria: Incomplete data entry records were 
excluded from the study. 
Methodology:  
The retrospective analysis of dermatology OPD records 
of 6 months (1st March 2018- 31st August 2018) was 
carried out during the study period. The proforma for 
collecting data was designed. Demographic details, di-
agnosis and treatment given for each patient were rec-
orded. The data collected was condensed, and the mas-
ter chart was prepared for data analysis. 
Statistical analysis: The overall information generated 
was entered in Microsoft excel sheet (2013 version), 
and results were expressed in the form of a percentage.  
 
RESULTS  
During the study period, a total of 3869 patient’s case 
records were studied and analysed.  Out of 3869 pa-
tients, 2361 (61%) patients were male, and 1508 (39%) 
patients were female. A maximum number of patients 
(26.5%) found in the age group 31-40 years, followed 
by 23.5% of patients in the age group 21- 30 years. Fun-
gal infection was found in 39.6 % of patients followed 
by acne in 14.2%patients and eczema in 9.1% of pa-
tients. Antihistaminics were the most commonly pre-
scribed drugs (45.02%), followed by antifungal (39.6%) 
and steroids (27.8%). Several drugs prescribed per pa-
tient were varied in between 1 to 7.  The average num-
ber of drugs per prescription was found to be 2.72.  
Fig 1. Gender wise distribution of the patients 
Fig 2. Age group wise distribution of the patients in 
percentage  
Fig 3. Number of drugs per prescriptions  
Fig 4. Distribution of common skin disease   
Levocetirizine (74.07%) and hydroxyzine (16.5%) were 
the most commonly prescribed antihistaminics. Itracon-
azole (58.17%) and Griseofulvin (24.67%) were the 
most commonly used oral antifungal drugs. Miconazole 
(73.73%) was the most commonly used topical antifun-
gal drug, followed by ketoconazole (12.45%). Among 
steroids, prednisone (52%) and betamethasone (38.05%) 
were the most commonly used steroids by oral route 
while clobetasol (68.09%) and mometasone (19.5%) 
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were the most commonly used steroids by topical route. 
Benzoyl peroxide (62.73%) was the most commonly 
used topical preparation for acne, followed by adapalene 
(22.14%) and tretinoin (10.15%).  
Fig 6. Most commonly used topical antifungal drugs  
Amoxicillin+ clavulanic acid (48.04%), azithromycin 
(30.04%) and doxycycline (16.11%) were the most 
commonly prescribed antibiotics in various dermatolog-
ical conditions. Our study revealed that the percentage 
of drugs prescribed from the WHO essential drug list 
was only 23.87%. Drugs which prescribed by the gener-
ic names were less than <1% 
DISCUSSION 
In our study, we have analysed the case records of 3869 
patients. Out of 3869 patients, 2361 (61%) patients were 
male, and 1508 (39%) patients were female. A maxi-
mum number of patients (26.5%) found in the age group 
31-40 years, followed by 23.5% of patients in the age 
group 21- 30 years. The similar result was observed in 
the study conducted by Pathak AK et al. [12] Fungal 
infection (39.6%) was the most common skin disorder 
noted in the patients followed by acne (14.2%) and ec-
zema (9.1%). A similar study conducted by Mothare 
VM et al. found scabies was the most common skin 
disorder while acne was the most common skin disorder 
noted in the study conducted by Pathak AK et al. [12, 
13].  An average number of drugs per prescription is 
considered as an important index of prescription analy-
sis. In our study, the average number of drugs per pre-
scription was noted to be 2.72. An average number of 
drugs per prescription was found to be very low as com-
pared to similar studies conducted by Sarkar et al. and 
Narwane et al. [9,10].  
The most commonly prescribed drugs in our study were 
antihistaminics (45.02%) followed by antifungal drugs 
(39.6%) and steroids (27.8%). In the study conducted by 
Tikoo D et al., antihistaminic was the most commonly 
prescribed drug group [14]. Most probable reason for 
the maximum use of antihistaminic drugs could be due 
to itching associated with many dermatological condi-
tions like fungal infections, eczema, psoriasis, scabies 
etc. In our study, we found that levocetirizine was the 
most commonly used antihistaminic drug, followed by 
hydroxyzine. Similar observation was also noted in the 
study conducted by Mohamed Saleem TL et al. [15] In 
our study; we found that itraconazole was the most 
commonly used oral antifungal drug and miconazole 
was the most commonly used topical antifungal drug. A 
similar study conducted by Mohamed Saleem TL et al. 
found that fluconazole was the most commonly used 
oral and miconazole was the most commonly used topi-
cal antifungal drug [15].  
In our study, we found that clobetasol was the most 
commonly used topical steroid and prednisone was the 
most commonly used oral steroid. Similar findings also 
found in the study conducted by Mohamed Saleem TL 
et al. [15] Amoxicillin + clavulanic acid, azithromycin 
and doxycycline were the most commonly used antimi-
crobial drugs. In our study, we came to know that <1 % 
of drugs were prescribed by the generic name. This val-
ue less than that reported in the study conducted by 
Sarkar C et al. and Muhammad J. et al.[9, 16]  Our 
study found that the percentage of drugs prescribed 
from WHO essential drugs list was only 23.87%, which 
is lower as compare to that found in the study conducted 
in North India by Alam K et al. [17] The low rate of 
prescribing from WHO essential drug list may be con-
tributed by excessive use of antihistaminics, antibiotics 
and several topical steroid preparations which are not 
included in WHO essential drug list.  
CONCLUSION 
Treatment protocols used in the management of skin 
disorders were near to the standard guidelines. Howev-
er, drugs prescribed by the generic name were very few. 
Also, only a few drugs were prescribed from the WHO 
essential drug list.  
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